Arrivato tender Valeant:
Bausch Health Companies Inc. has offered to purchase, for cash, up to an aggregate purchase price of 1.5 Billion USD of its outstanding notes, including the 5.875% Senior Notes Due 2023.
Please be aware restrictions may apply in the following jurisdictions: United Kingdom, Canada, Ireland, Belgium, France, Italy, New Zealand, Switzerland, and the People´s Republic of China.
By submitting an election to this offer, the account holder confirms they have independently verified the terms of, and their eligibility to participate in, the offer and therefore confirms the account meets all eligibility requirements.
Terms of the offer are as follows (subject to proration):
Option 1 - Take no action
Option 2 - Tender notes for cash: 986.16 USD + 30.00 USD Early Tender Premium + Accrued Interest per 1,000 Principal Amount tendered and accepted.
Please Note: The Early Tender Premium will only be payable to holders who validly tender their notes prior to the Early Tender Deadline, unless extended.
Minimum Tender Requirement: 2,000 principal amount and in multiples of 1,000 thereafter, holders who do not tender all their notes must continue to hold the minimum authorized denomination of 2,000.
If the principal amount of notes that are unaccepted and returned to a holder as a result of proration would result in less than the minimum authorized denomination, all of such validly tendered notes will either be accepted or rejected.
Guaranteed Delivery: No
Last day to purchase and be eligible to tender: 2019-05-20
The Early Tender Deadline to tender notes to the offer will be 2019-05-22 @ 13:00 (America/New York).
The Final Deadline to tender notes to the offer will be 2019-06-06 @ 13:00 (America/New_York).